Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.390
-0.010 (-0.71%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $393.74 million as of April 25, 2025. Its market cap has increased by 17.36% in one year.
Market Cap
393.74M
Enterprise Value
5.16M
1-Year Change
17.36%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $393.74M, a decrease of -78.81%. That is a compound annual growth rate of -33.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 393.74M | -44.52% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |